How big is the Chronic Disease Management Market?
According to 6Wresearch internal database and industry insights, the
Global chronic disease management market was valued at approximately USD 7.4 billion in 2024 and is projected to reach USD 13.2 billion by 2031, growing at a CAGR of 8.7%.
This growth is driven by the increasing global burden of chronic conditions like diabetes, cardiovascular diseases, and respiratory disorders, along with rising adoption of digital health solutions.
Key Growth Drivers of the Chronic Disease Management Market
- Rising prevalence of lifestyle-related chronic illnesses such as diabetes and hypertension
- Growing adoption of digital tools for remote monitoring and personalized care
- Government initiatives promoting preventive care and health IT infrastructure
- Advancements in telehealth, wearable tech, and mobile health applications
- Expansion of value-based care models focused on long-term disease control
Chronic Disease Management Market Trends
The chronic disease management market is experiencing a shift toward tech-enabled, patient-centric care models. Digital platforms, AI-driven risk analytics, and connected devices are being used for real-time monitoring and early intervention. Remote patient management is gaining traction among payers and providers due to its potential to reduce hospitalizations. Integration of EHRs, personalized care pathways, and predictive analytics is enhancing treatment outcomes. Emerging markets are adopting mobile health tools rapidly to improve accessibility and engagement.
Emerging Developments in the Chronic Disease Management Market
Recent developments in the chronic disease management market include AI-powered decision support systems and remote diagnostic tools. Companies are developing integrated care platforms that offer virtual coaching, medication tracking, and behavioral health support. Interoperability improvements between healthcare systems and apps are allowing for better data sharing and coordination. Strategic collaborations between healthcare providers, insurers, and tech firms are accelerating personalized, scalable care models across geographies.
Major Companies in the Chronic Disease Management Market
- Philips Healthcare
- Omada Health
- Medtronic plc
- Teladoc Health, Inc.
- Cerner Corporation (Oracle Health)
- Health Catalyst
- Allscripts Healthcare Solutions
- Lark Health
- Welldoc, Inc.
- Livongo Health (a Teladoc Health company)
How big is the Chronic Disease Management Market : FAQ's
The chronic disease management market was valued at USD 7.4 billion in 2024 and is projected to reach USD 13.2 billion by 2031.
The chronic disease management market is projected to grow at a CAGR of 8.7% between 2025 and 2031.
Diabetes care, cardiovascular health, respiratory disease management, hypertension, and behavioral health.
Rise in chronic conditions, digital healthcare adoption, patient engagement tools, and shift to value-based care.
Data privacy issues, system integration challenges, patient non-compliance, and healthcare access gaps.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com